Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joel Jaimes-Santoyo"'
Autor:
Katy Sánchez-Pozos, MA Granados-Silvestre, NG Nieto-Velázquez, María Alicia Mejía-Blanquel, Natsyelli Galicia-Martínez, Jessica Mandujano-Cerón, Joel Jaimes-Santoyo, María Guadalupe Ortiz-López
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Type 2 diabetes (T2D) has become an epidemic. Delays in diagnosis and as a consequent late treatment has resulted in high prevalence of complications and mortality. Secreted frizzled-related protein 4 (SFRP4), has been recently id
Externí odkaz:
https://doaj.org/article/84f4081e4e974bfc9d88604470293b4d
Autor:
Katy Sánchez-Pozos, JazmÃn Monroy-Escutia, Joel Jaimes-Santoyo, Mª de los Ãngeles Granados-Silvestre, Marta Menjivar, Mª Guadalupe Ortiz-López
Publikováno v:
Gaceta Médica de México, Vol 89, Iss 2 (2021)
Introduction: Diabetic neuropathy (DN) is one of the most common complications of type 2 diabetes (T2D) and is a leading cause of lower limb amputation. The aim of the present study was to evaluate the risk factors contributing to DN in Mexican patie
Externí odkaz:
https://doaj.org/article/c8772a367b8541248d789b1bff3334be
Autor:
Katy, Sánchez-Pozos, Jazmín, Monroy-Escutia, Joel, Jaimes-Santoyo, Ma de Los Ángeles, Granados-Silvestre, Marta, Menjivar, Ma Guadalupe, Ortiz-López
Publikováno v:
Cirugía y Cirujanos (English Edition). 89
Diabetic neuropathy (DN) is one of the most common complications of type 2 diabetes (T2D) and is a leading cause of lower limb amputation. The aim of the present study was to evaluate the risk factors contributing to DN in Mexican patients through th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f165ae0f60e31ce028cd27acaf8980
https://doi.org/10.24875/cirue.m20000272
https://doi.org/10.24875/cirue.m20000272
Autor:
Menjivar Marta, Jazmin Monroy-Escutia, María de los Ángeles Granados-Silvestre, María Guadalupe Ortiz-López, Joel Jaimes-Santoyo, Katy Sánchez-Pozos, Carolina Rivera Santiago
Publikováno v:
Current Drug Metabolism. 21:291-300
Background:In Mexico, approximately 25% of patients with type 2 diabetes (T2D) have adequate glycemic control. Polymorphisms in pharmacogenetic genes have been shown to have clinical consequences resulting in drug toxicity or therapeutic inefficacy.O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8517cca9f7e7629a14e5c4e658ea47dd
https://doi.org/10.2174/1389200221666200514125443
https://doi.org/10.2174/1389200221666200514125443
Autor:
Marta Menjivar, María de los Ángeles Granados-Silvestre, Katy Sánchez-Pozos, Jazmin Monroy-Escutia, María Guadalupe Ortiz-López, Joel Jaimes-Santoyo
Publikováno v:
Cirugía y Cirujanos. 89
Introduction Diabetic neuropathy (DN) is one of the most common complications of type 2 diabetes (T2D) and is a leading cause of lower limb amputation. The aim of the present study was to evaluate the risk factors contributing to DN in Mexican patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c84db8f3c3eef10e88779d24032f5dab
https://doi.org/10.24875/ciru.20000243
https://doi.org/10.24875/ciru.20000243